Determination of oxaliplatin in human plasma and plasma ultrafiltrate by graphite-furnace atomic-absorption spectrometry

E. E. M. Brouwers(Slotervaartziekenhuis), Jos H. Beijnen(The Netherlands Cancer Institute), Jan H.M. Schellens(Utrecht University), Hilde Rosing(The Netherlands Cancer Institute), Matthijs M. Tibben(Slotervaartziekenhuis), Olaf van Tellingen(Dutch Cancer Society), Markus Joerger(Kantonsspital St. Gallen)
Analytical and Bioanalytical Chemistry
June 10, 2005
10.1007/s00216-005-3302-5
Cited by 29

Related Papers

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
|Cell|1994|2.3k
Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E–Mutated Colorectal Cancer
|New England Journal of Medicine|2019|1.5k
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
|Proceedings of the National Academy of Sciences|1997|941
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
|Proceedings of the National Academy of Sciences|1997|884